Mitsubishi UFJ Trust & Banking
IBRX icon

Mitsubishi UFJ Trust & Banking’s ImmunityBio IBRX Stock Holding History

Mitsubishi UFJ Trust & Banking’s Portfolio IBRX Stock Details IBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$141K Buy
+16,058
New +$122K ﹤0.01% 1428

Other funds holding IBRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SAM
SEB Asset Management Stockholm $26.6B AUM
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
CCA
Clearwater Capital Advisors Hoffman Estates, Illinois $1.36B AUM 18.79% 1-Year Est. Return
AH
Allen Holding New York $1.01B AUM 14.43% 1-Year Est. Return
KA
Kercheville Advisors San Antonio, Texas $328M AUM 76.85% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Mitsubishi UFJ Trust & Banking's IBRX Position: Q2 2026 in Review

Mitsubishi UFJ Trust & Banking opened a new position in ImmunityBio (IBRX) in Q2 2026: 16,058 shares worth $141K. The stake represents ﹤0.01% of the portfolio and ranks #1428 among its holdings.

205 funds tracked by Wall St. Rank hold IBRX as of Q2 2026.

  • Mitsubishi UFJ Trust & Banking held 16,058 shares of ImmunityBio worth $141K as of Q2 2026.
  • ImmunityBio was a new Mitsubishi UFJ Trust & Banking position in Q2 2026.
  • ImmunityBio made up ﹤0.01% of Mitsubishi UFJ Trust & Banking's portfolio in Q2 2026, its #1428 holding.
  • 205 funds tracked by Wall St. Rank held ImmunityBio as of Q2 2026.

Based on Mitsubishi UFJ Trust & Banking's 13F filing for Q2 2026, filed 6 Aug 2026.